Publication | Open Access
Transcriptional Signature and Memory Retention of Human-Induced Pluripotent Stem Cells
308
Citations
37
References
2009
Year
Adult Stem CellRegenerative MedicineMemory RetentionInduced Pluripotent Stem CellsMemoryStem CellsGenetic ReprogrammingHealth SciencesGene TransferGene ExpressionCell BiologyInduced Pluripotent Stem CellDevelopmental BiologyStem Cell ResearchStem-cell TherapyGene VectorHuman IpscsMedicineGenome EditingEmbryonic Stem CellSimilar Human Ipscs
Genetic reprogramming of somatic cells to induced pluripotent stem cells has been achieved in mouse and human cells, yet the extent to which human iPSCs resemble human embryonic stem cells remains uncertain. Human fetal neural progenitor cells were reprogrammed without viral vectors or genomic insertions by transfecting episomal vectors carrying Oct4 and Nanog. The resulting episomal iPSCs exhibit a transcriptional profile largely similar to hESCs while preserving donor‑cell gene expression, and the method proves efficient and safe for clinical and basic research.
Genetic reprogramming of somatic cells to a pluripotent state (induced pluripotent stem cells or iPSCs) by over-expression of specific genes has been accomplished using mouse and human cells. However, it is still unclear how similar human iPSCs are to human Embryonic Stem Cells (hESCs). Here, we describe the transcriptional profile of human iPSCs generated without viral vectors or genomic insertions, revealing that these cells are in general similar to hESCs but with significant differences. For the generation of human iPSCs without viral vectors or genomic insertions, pluripotent factors Oct4 and Nanog were cloned in episomal vectors and transfected into human fetal neural progenitor cells. The transient expression of these two factors, or from Oct4 alone, resulted in efficient generation of human iPSCs. The reprogramming strategy described here revealed a potential transcriptional signature for human iPSCs yet retaining the gene expression of donor cells in human reprogrammed cells free of viral and transgene interference. Moreover, the episomal reprogramming strategy represents a safe way to generate human iPSCs for clinical purposes and basic research.
| Year | Citations | |
|---|---|---|
Page 1
Page 1